Contributors

From the Editors

Cost Management
Q2 2023 Gene Therapy Report: Promising New Treatments on the Horizon
An update on the gene therapy pipeline More
Briefing
Specialty
7 Stats That Show What Providers Think About Biosimilars
7 stats that show what providers think about biosimilars More
Briefing
Specialty
Advancing Our Clinical Agenda
Advancing Caremark’s clinical agenda through population health More
Commentary
Cost Management
The Dynamic PBM Landscape
The changing PBM landscape holds challenges for payors More
Commentary
Specialty
Member Experience: A Specialty Patient’s Journey
Member Experience: A Specialty Patient’s Journey More
Briefing
Cost Management
Connected in Care: A Proactive Approach to Managing Specialty Drugs
Lowering specialty costs through ongoing engagement with members More
Briefing
Innovation
Understanding Environmental Threats to Member Health
Environmental threats to plan member health More
Briefing
Innovation
Advancing Our Technology Roadmap
Advancing Our Technology Roadmap More
Briefing